Quel est le prix pour MedCap AB (publ) (MCAP)

Le prix pour MedCap AB (publ) (MCAP) est $63.50

Quelle est la capitalisation boursière pour MedCap AB (publ) (MCAP)

La capitalisation boursière pour MedCap AB (publ) (MCAP) est $950.92M

MedCap AB (publ) (MCAP) BPA

MedCap AB (publ) operates as a private equity firm, employing a diverse array of investment strategies including secondary direct deals, later-stage funding, industry consolidation, growth capital provision, engagement with middle-market and mature businesses, turnarounds, and outright buyouts. The company primarily directs its capital towards businesses within the healthcare sector, focusing on medical equipment and services, biotechnology, life sciences, and pharmaceuticals. It actively seeks unlisted, small to mid-sized companies located predominantly across Northern Europe. Equity investments typically fall within the SEK 25 million to SEK 150 million range (approximately $2.75 million to $16.51 million). Target companies generally exhibit an enterprise value and annual sales revenue between SEK 50 million and SEK 200 million ($5.90 million to $23.06 million), alongside an EBITDA of SEK 1 million to SEK 50 million ($0.11 million to $5.50 million). MedCap aims to acquire ownership stakes of 20% to 50% in its portfolio entities, financing these through its own capital, loans, and direct balance sheet investments. Established in 2001, the firm maintains its headquarters in Stockholm, Sweden.

Année	EPS	Changez
Pas assez de données pour les dates fournies.

Année

EPS

Changez

Pas assez de données pour les dates fournies.

Entreprise	EPS	Différence d’EPS	Pays
BlackRock, Inc. BLK.US	$42.39	-	US
Blackstone Inc. BX.US	$4.50	-	US
Investor AB (publ) INVE-A.ST	-	-	SE
KKR & Co. Inc. KKR.US	$3.36	-	US
Brookfield Asset Management Ltd. BAM.US	$1.74	-	US

Entreprise

EPS

Différence d’EPS

Pays